AI assistant
CONMED Corp — Director's Dealing 2013
Aug 2, 2013
31971_dirs_2013-08-02_84a74a25-9ea4-436b-840b-a1411c034d6d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2013-07-26
Reporting Person: CONCANNON BRIAN (Director)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Rsus (restricted Stock Units) | $0 | 2023-07-26 | Common Stock (3000) | Direct | |
| Sars (Stock Appreciation Rights) | $33.43 | 2023-07-26 | Common Stock (1000) | Direct |
Footnotes
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2007 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period.
F2: The stock appreciation rights ("SARs") were granted under the Company's 2007 Amended and Restated Non-Employee Director Equity Compensation Plan, with the SARs generally vesting 100% after a one year period.